POS0266 CELLULAR IMMUNE RESPONSE PERSISTENCE AFTER COVID-19 MRNA VACCINES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS UNDER RITUXIMAB - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Annals of the Rheumatic Diseases Année : 2023

Dates et versions

hal-04488910 , version 1 (04-03-2024)

Identifiants

Citer

J. Marin, P. Bourgoin, N. Saverna, C. Cartagena García, P. Lafforgue, et al.. POS0266 CELLULAR IMMUNE RESPONSE PERSISTENCE AFTER COVID-19 MRNA VACCINES AMONG PATIENTS WITH RHEUMATOID ARTHRITIS UNDER RITUXIMAB. Annals of the Rheumatic Diseases, 2023, pp.370.2-371. ⟨10.1136/annrheumdis-2023-eular.3996⟩. ⟨hal-04488910⟩
11 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More